So much action here, day to day 30% swings, ups and downs...but in the end, they have a product which now is going to be sold in minimum 7 European countries.M&A target, partnership with big pharma..all possible. But what is a guarantee is sales.52 week high is just over $9 mainly on speculation of FDA approval. Based on the EU developments and opportunities there is no reason we can not see that 52 week high with in the next few months.Thoughts?I am long in ALIM
I agree. For the past 3 years ALIM traded around $10. It was the FDA rejection of ILUVN that dropped to $1. Now, it's recovering nicely.But, when is the FDA approval/disapproval date?
the FDA full rejection letter was back in November. ALIM has stated they will NOT resubmit for FDA approval any time soon. It looks like their focus is over seas. Doesn't matter, sales are sales!